Making a Cell Therapy: Principles and Practice of Manufacturing (edX)
Categories
Effort
Languages
Self Paced
Stacy L. Springs
Dr. Stacy Springs serves as the Senior Director of Programs at MIT's Center for Biomedical Innovation and as the Executive Director of Biomanufacturing Initiatives including MIT's Biomanufacturing Program, (BioMAN), its Consortia on Adventitious Agent Contamination in Biomanufacturing, (CAACB), and the BioACCESS initiative. The objective of BioMAN is to develop knowledge, science, technologies and strategies that advance the global manufacture and delivery of high quality biopharamaceuticals. The CAACB pools biopharmaceutical manufacturing expertise in the area of adventitious agent contamination to better enable a safe and dependable delivery of life-saving biologics. BioACCESS seeks to better understand the growing need for and barriers to safe, effective, and affordable health services in low- and middle-income countries, especially biologic therapies for chronic and non-communicable diseases. In addition, Dr. Springs serves as the Executive Director for the MIT Sloan’s Food Supply Chain Analytics and Sensing Initiative, (FSAS).
She holds a PhD in Chemistry from the University of Texas at Austin and gained postdoctoral training in protein and biophysical chemistry at Princeton University.